New AI-powered retinal cameras can detect diabetic eye disease in just seconds — even in clinics or pharmacies — allowing ...

VISION 2020: The Right to Sight – India has released the revised National Guidelines for the Management of Diabetic ...

Diabetic Retinopathy Patient Summit organized by Dr Agarwals Eye Hospitals, across India Group offers Free diabetic eye ...

As Ghana joins the global community in observing Diabetic Eye Disease Awareness Month this November, a sobering reality ...

Housing instability, food insecurity and other factors related to social deprivation come with significantly greater risks ...

Diabetic retinopathy, a leading cause of blindness in working-age adults, silently damages eyes through high blood sugar.

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

November is observed as Diabetic Eye Disease Awareness Month, a month dedicated to educating people about the serious eye ...

Diabetic eye damage can begin early, even before diagnosis, silently threatening vision. Early screenings and lifestyle ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

India has introduced revised national guidelines aimed at reducing blindness caused by diabetic retinopathy, a complication of diabetes affecting millions of Indians.